Next-generation sequencing (NGS) is transforming research by delivering rapid, high-quality genetic data through streamlined workflows, automation, and advanced logistics. Eurofins Genomics combines ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Download this application note to learn more about targeted sequencing approaches such as RNA exome sequencing. Is the form ...

TheFly reported on April 10 that Piper Sandler began coverage of CAI with a Neutral rating and a $21 price target.

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Increasing prevalence of bleeding disorders, rising number of surgical procedures, aging population, and growing focus on interoperability are the major factors which drive global market growth.WILMIN ...

According to a new report published by Allied Market Research, the global Genomics Services Market was valued at $8.3 billion ...

Life science company 10x Genomics has launched Atera, a biology platform designed to deliver whole-transcriptome spatial ...

Liquid chromatography–mass spectrometry (LC-MS) enabled comprehensive profiling of metabolites produced by cucumber glandular ...

A robust and quantitative map links chromatin modification and gene expression of cells during zebrafish embryogenesis.

IRVING, Texas, April 20, 2026 /PRNewswire/ -- Caris Life Sciences (R) (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced it ...

10x Genomics TXG recently unveiled Atera, a next-generation in situ spatial biology platform designed to deliver ...